Novo Nordisk Pharmatech helps the world´s largest biopharmaceutical and pharmaceutical industries reduce their risk for raw materials by using pharma-grade products with a high level of consistency, purity, quality, and reliability.
The product range consists of Recombinant Insulin, Quaternary ammonium compounds (Quats), Customised Purification Resins, and Specialty Enzymes.
The high-purity, non-therapeutic Recombinant Insulin is sourced directly from parent company Novo Nordisk, the world’s largest insulin producer.
Recombinant Insulin stimulates the proliferation of cells, enhances the yield, and is a key component in serum-free growth media for mammalian cells. It is used to manufacture monoclonal antibodies, virus vaccines, gene therapy products, and other biological drug products approved by regulatory bodies worldwide.